miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis

Figure 2

miR-20b inhibits T cell proliferation. (a) Expression levels of miR-20b as determined by qRT-PCR in Jurkat cells 48 h after transfection with either miR-20b or anti-miR-20b or their respective controls (miR-NC or anti-miR-NC). ; . (b) Cell proliferation was determined by MTT assays in Jurkat cells transfected with either miR-20b or anti-miR-20b or their respective controls (miR-NC or anti-miR-NC). . (c) Flow cytometry based cell proliferation assays and quantification in Jurkat cells transfected with either miR-20b or anti-miR-20b or their respective controls (miR-NC or anti-miR-NC). ; .